New York: COVID-19 vaccines developed by BioNTech SE and Moderna lowered the infection risk by 80 per cent two weeks or more after the first jab, revealed the data from ...
Washington: Pfizer Inc and German partner BioNTech SE have started testing their COVID-19 vaccine on children aged under 12. Pfizer is hoping to start vaccination of children by early 2022. ...
New Delhi: Pfizer has decided to withdraw the application for emergency use authorisation of its COVID-19 vaccine in India, the pharmaceutical major said on Friday. Incidentally, the US company was ...
Bhubaneswar: While some COVID-19 vaccines such as Oxford-AstraZeneca, Pfizer and Moderna have been launched for emergency use in parts of the world, here are some other vaccines in development. The ...
London: Two nursing home residents have died two days after receiving shots of the Pfizer-BioNTech COVID-19 vaccine. The Norwegian Medicines Agency is assessing whether the cause of death is the ...
London: BioNTech is confident that the COVID-19 vaccine it developed with Pfizer will be effective against the new "UK" strain of the coronavirus. If required, a new vaccine can be ...
New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with ...
Singapore: Singapore joins the list of nations to approve the Pfizer-BioNTech COVID-19 vaccine. The first shots will be delivered by end of December, Prime Minister Lee Hsien Loong said on ...
Washington: The US Food and Drug Administration (FDA) has given authorisation to the emergency use of the Pfizer coronavirus vaccine candidate in the country. The US authorisation comes days after ...
Washington: Hours after approving the Pfizer COVID-19 vaccine for emergency use, the US government placed an order to secure 100 million more doses from Moderna. Earlier, the US had decided ...
Copyright © 2024 Frontier Media
